Who I Run For: My Dad
Within three years of his diagnosis with aggressive prostate cancer, Dick Treat lost his battle to cancer at the age of 66—leaving behind a wife, two sons, two daughters and five grandsons. Dick’s story is not uncommon. In fact, in 2012, more than 28,000 other men will lose their life to prostate cancer.
Dick’s diagnosis came at a pivotal time for his family—his oldest daughter was just married, his sons were expanding their families with children and his youngest, Katie, had just graduated college. These important milestones in his children’s lives led Dick and his wife to keep the severity of his disease quiet until they heard the same results from multiple doctors. And for the next two years, the Treat family spent quality time together, taking family vacations to some of Dick’s favorite destinations and enjoying life with one another. “As awful as it was, he remained so positive—he didn’t want to let anyone worry about him,” adds Katie.
After his passing, Katie was left wondering, what could she do to help educate men and raise awareness for a disease that affects 1 in 6 American men?
Though not an avid runner, Katie ran her first marathon shortly after college and played soccer her entire life. Her dad was always at her practices and games, rain or shine. After signing up for her second marathon and participating as an Athlete for a Cure last September, Katie looked for opportunities to continue raising awareness for the cause. Katie is now a team captain for Athletes for a Cure at the San Jose Muddy Buddy and will be wearing light blue for her dad, the official awareness color of prostate cancer.
Katie is also the aunt to five boys—a role she takes very seriously. Dollars raised through the Prostate Cancer Foundation and Athletes for a Cure will no doubt have an impact on these boys’ lives, “I know the money raised today has the potential to save their life.”
With supporters like Katie, and the Prostate Cancer Foundation and Athletes for a Cure are raising awareness and funds for the fight against prostate cancer.